Results 51 to 60 of about 3,031 (144)

Hepatitis C Drugs: The End of the Pegylated Interferon Era and the Emergence of All-Oral, Interferon-Free Antiviral Regimens: A Concise Review

open access: yesCanadian Journal of Gastroenterology and Hepatology, 2014
Between 2001 and 2011, the standard of care for chronic hepatitis C virus (HCV) infection was a combination of pegylated interferon (PEGIFN) and ribavirin (RBV).
Alan Hoi Lun Yau, Eric M Yoshida
doaj   +1 more source

Effectiveness and tolerability of direct-acting antivirals for chronic hepatitis C patients in a Southern state of Brazil

open access: yesBrazilian Journal of Infectious Diseases
Background This study aimed to evaluate the clinical effectiveness in terms of sustained virological response and tolerability of available second generation direct-acting antivirals in Brazilian patients.
Vinicius Lins Ferreira   +7 more
doaj   +1 more source

A simeprevir-inducible molecular switch for the control of cell and gene therapies. [PDF]

open access: yesNat Commun, 2023
Chin SE   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy